Janssen Research & Development, LLC
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Janssen Research & Development, LLC is a clinical trial sponsor. It has 166 active clinical trials with 93,882 planned participants, across 16 therapeutic areas. Since 2021 it has completed 359 trials and stopped 71 early.
Trial track record · since 2021
Pipeline · 166 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Janssen Research & Development, LLC
Janssen Research & Development, LLC is lead sponsor of 166 active clinical trials on ClinicalTrials.gov, with 93,882 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 359 trials and stopped 71 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Janssen Research & Development, LLC; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-14.
Approve Suite is not affiliated with Janssen Research & Development, LLC. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.